Medplus Health Services Ltd (Pharmacy Distribution) — fundamental analysis, earnings data, and key metrics. PE: 48.0. ROE: 8.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on Q3 FY26 earnings • Updated Mar 14, 2026
What: Incentive structure shift from private-label-only to total sales growth driving immediate SSSG improvement
Impact: +₹300 Cr revenue
“Management stated: 'Success is due to hitting a lower base from the previous year, warehouse availability improvements, and the revised incentive structure that rewards total sales rather than just private label'”
What: Aggressive addition of non-pharma categories (food, wellness) with higher margins and no substitution risk
Impact: +₹500 Cr revenue
“Madhukar Reddy stated: 'These carry 25-28% gross margins without the substitution risk seen in pharma'”
What: Deepening presence in existing states to improve logistics efficiency and working capital
Impact: +₹200 Cr revenue
“Management guidance: 'Priority is deepening presence in existing states to optimize warehouse utilization before major new state entries'”
Earnings deceleration risks from management commentary
Trigger: Franchisee sales >30% of total revenue
Impact: -100 bps margin impact
Management view: Management acknowledged trade-off for faster expansion with lower capital intensity
Monitor: Franchisee revenue mix
Trigger: Quick-commerce captures >15% market share
Impact: -150 bps margin impact
Management view: Requires continuous investment in logistics and 'on-time' service capabilities
Monitor: Logistics cost as % revenue
Key quotes from recent conference calls
“Success is due to hitting a lower base from the previous year, warehouse availability improvements, and the revised incentive structure that rewards total sales rather than just private label — Sujit Mahato”
“The company is aggressively adding non-pharma categories (food, wellness, cold-pressed oils) to leverage its 5,000-store scale. These carry 25-28% gross margins without the substitution risk seen in pharma — Madhukar Reddy”
“Priority is deepening presence in existing states to optimize warehouse utilization before major new state entries — Management”
“Remaining 200 stores to be added in Q4; FY27 expected to maintain a similar run rate — Management”
Forward-looking targets from management for FY26-FY27
Key Milestones
• 600 net store additions for FY26
• Maintain similar store addition run rate for FY27
• Focus on densifying existing clusters
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Mar 14, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Medplus Health Services Ltd's latest quarterly results (Dec 2025) show
Medplus Health Services Ltd's current PE ratio is 48.0x.
Medplus Health Services Ltd's price-to-book ratio is 5.4x.
Medplus Health Services Ltd's fundamental strength based on key financial ratios
Medplus Health Services Ltd has a debt-to-equity ratio of N/A.
Medplus Health Services Ltd's return ratios over recent years
Medplus Health Services Ltd's operating cash flow is positive (FY2025).
Medplus Health Services Ltd currently does not pay a significant dividend (yield 0.00%).
Medplus Health Services Ltd's shareholding pattern (Dec 2025)
Medplus Health Services Ltd's promoter holding has remained stable recently.
Medplus Health Services Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Medplus Health Services Ltd has 3 key growth catalysts identified from recent earnings analysis
Medplus Health Services Ltd has 2 key risks worth monitoring
In Q3 FY26, Medplus Health Services Ltd's management highlighted
Medplus Health Services Ltd's management has provided the following forward guidance for FY26-FY27
Based on quantitative research signals, here is why Medplus Health Services Ltd may be worth studying
Medplus Health Services Ltd investment thesis summary:
Medplus Health Services Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
